Evaluation of Charcoal Hemoperfusion in Uremia

  • James F. Winchester


This paper deals primarily with the evaluation of activated charcoal hemoperfusion in the management of the uremic patient. The studies were performed on a short-time basis (1, 2), and no long term studies of the particular charcoal hemoperfusion device used in these studies have been performed. Chang, et al (3, 4) have published the only long-term studies of charcoal hemoperfusion in the management of uremia.


Blood Flow Rate Uremic Patient Hepatic Coma Artificial Kidney Solute Clearance 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Winchester, J.F., Apiliga, M.T., Mackay, J.M., Kennedy, A.C. Haemodialysis with charcoal haemoperfusion. Proc Eur Dial Transplant Assoc 12:526–533, 1975.Google Scholar
  2. 2.
    Winchester, J.F., Apiliga, M.T., Kennedy, A.C. Short-term evaluation of charcoal hemoperfuslon combined with dialysis in uremic patients. Kidney Int 10:S315-S319, 1976.Google Scholar
  3. 3.
    Chang, T.M.S., Migchelsen, M., Coffey, J.F., Stark, A. Serum middle molecule levels In uremia during long-term Intermittent hemoperfusions with the ACAC (coated charcoal) microcapsule artificial kidney. Trans Amer Soc Artif Int Organs 20:364–371, 1974.Google Scholar
  4. 4.
    Chang, T.M.S. Hemoperfuslon alone and in series with ultrafiltration or dialysis for uremia, poisoning, and liver failure. Kidney Int 10:S305-S311, 1976.Google Scholar
  5. 5.
    Bryan, F.A. Sixth Annual Progress Report, National Dialysis Registry, 1973–1974.Google Scholar
  6. 6.
    Brunner, F.P., Giesecke, B., Gurland, H.J., Jacobs, C., Parsons, F.M., Scharer, K., Seyffart, G., Spies, G., Wing, A.J. Combined report on intermittent dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc 12:3–64, 1975.Google Scholar
  7. 7.
    Kolff, W.J., Berk, H.T.J. Artificial kidney: Dialyzer with great area. Acta Med Scan 117:121–134, 1944.CrossRefGoogle Scholar
  8. 8.
    Dall’Aglio, P., Buzio, C., Cambi, V., Arisi, L., Migone, L. La retention de moyennes molecules dans le serum uremique. Proc Eur Dial Transplant Assoc 9:409–415, 1972.PubMedGoogle Scholar
  9. 9.
    Winchester, J.F., Edwards, R.O., Tilstone, W.J., Woodcock, B.G. Activated charcoal hemoperfusion and experimental acetaminophen poisoning. Toxicol and Appl Pharmacol 31:120–127, 1975.CrossRefGoogle Scholar
  10. 10.
    Chang, T.M.S., Chirito, E., Barre, B., Cole, C., Hewish, M. Clinical performance characteristics of a new combined system for simultaneous hemoperfusion-hemodialysis ultrafiltration in series. Trans Amer Soc Artif Int Organs 21:502–508, 1975.Google Scholar
  11. 11.
    Swank, R.L., Roth, J.G., Jansen, L. Screen filtration pressure method and adhesiveness and aggregation of blood cells. J Appl Physiol 19:340–346, 1964.PubMedGoogle Scholar
  12. 12.
    Chang, T.M.S., Coffey, J., Lister, C., Stark, A., Taroy, E. The efficiency of the ACAC microcapsule artificial kidney for the removal of glutethimide, methyprylon, and methaqualone in patients with acute intoxication. Trans Amer Soc Artif Int Organs, 19:87–91, 1973.CrossRefGoogle Scholar
  13. 13.
    Vale, J.A., Rees, A.J., Widdop, B., Goulding, R. Use of charcoal hemoperfusion in the management of severely poisoned patients. Br Med J 1:5–9, 1975.PubMedCrossRefGoogle Scholar
  14. 14.
    Gelfand, M.C., Winchester, J.F., Knepshield, J.H., Hanson, K.M., Cohan, S.L., Strauch, B.S., Geoly, K.L., Kennedy, A.C., Schreiner, G.E. Charcoal hemoperfusion in severe drug overdosage. Trans Amer Soc Artif Int Organs 23 (In press), 1977.Google Scholar
  15. 15.
    Winchester, J.F. Clinical Application of haemoperfusion in uraemia. In Artificial Organs (Ed. R.M. Kenedi, J.M. Courtney, J. Gaylor, T. Gilchrist), Macmillan Press, Ltd., London & Basingstoke, 1977 (In press).Google Scholar
  16. 16.
    Hermann, J., Rudorff, K.H., Gockenjan, G., Konigshausen, Th. Grabensee, B., Kruskemper, H.L. Charcoal haemoperfusion in thyroid storm. Lancet 1:248, 1977.CrossRefGoogle Scholar
  17. 17.
    Gazzard, B.G., Portmann, B.A., Weston, M.J., Langley, P.G. Murray-Lyon, I.M., Dunlop, E.H., Flax, H., Mellon, P.J., Record, CO., Ward, M.B., Williams, R. Charcoal haemoper-fusion in the treatment of fulminant hepatic failure. Lancet 1:1301–1307, 1974.PubMedCrossRefGoogle Scholar
  18. 18.
    Gelfand, M.C., Knepshield, J.H., Cohan, S., Ramirez, B., Schreiner, G.E. Treatment of hepatic coma with hemoperfusion through Polyacrylamide hydrogel coated charcoal. Kidney Int 10:S239-S243, 1976.CrossRefGoogle Scholar
  19. 19.
    Kennedy, A.C. In Discussion, Proc Eur Dial Transplant Assoc 13:270, 1976.Google Scholar
  20. 20.
    Babb, A.L., Popovich, R.P., Christopher, T.G., Scribner, B.H. The genesis of the square meter hypothesis. Trans Amer Soc Artif Int Organs 17:81–91, 1971.Google Scholar
  21. 21.
    Fürst, P., Asaba, M., Gordon, A., Zimmerman, L., Bergstrom, J. Middle molecules in uremia. Proc Eur Dial Transplant Assoc 11:417–426, 1974.Google Scholar
  22. 22.
    Yatzidis, H. A convenient haemoperfusion micro-apparatus over charcoal for the treatment of endogenous and exogenous intoxications. It use as an artificial kidney. Proc Eur Dial Transplant Assoc 1:83–97, 1964.Google Scholar
  23. 23.
    Johnson, W.J., Hagge, W.W., Wagoner, R.D., Dinapoli, R.P. Rosevear, J.W. Toxicity arising from urea. Kidney Int 7:S288-S293, 1975.Google Scholar
  24. 24.
    Jones, J.D., Burnett, P.C. Creatinine metabolism and toxicity. Kidney Int 7:S294-S298, 1975.Google Scholar
  25. 25.
    Oules, R., Asaba, H., Baum, A, Fürst, P., Gunnarson, B., Bergstrom, J. The removal of uremic small and middle molecules and free amino acids by charcoal hemoperfusion. Trans Amer Soc Artif Int Organs 23 (In press), 1977.Google Scholar
  26. 26.
    Avram, M.M., Lipner, H.I., Sadiqali, R., Iancu, M., Gan, A.C. Metabolic changes in diabetic uremic patients on hemodialysis. Trans Amer Soc Artif Int Organs 22:412–418, 1976.Google Scholar
  27. 27.
    Pavone-Macaluso, M., Alexander, R.W., Goering, R.B., Galletti, P.M. Parabiotic dialysis. Trans Amer Soc Artif Int Organs 10:285, 1964.Google Scholar
  28. 28.
    Winchester, J.F. Haemostatic changes induced by adsorbent haemoperfusion. In Artificial Organs, Ed. R.M. Kenedi, J.M. Courtney, J. Gaylor, T. Gilchrist, Macmillan Press, Ltd., London & Basingstoke, (In press), 1977.Google Scholar
  29. 29.
    Weston, M.J., Williams, R., Experience with haemoperfusion in fulminant hepatic failure. Proc First International Symposium on Gastrointestinal Emergencies. (In press), 1975.Google Scholar
  30. 30.
    Winchester, J.F., Forbes, C.D., Lang, S., Courtney, J.M., Prentice, C.R.M. Platelet function regulating agents-experimental data relevant to renal disease. In Thromboembolism A New Approach to Therapy. Academic Press (in press), 1977.Google Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • James F. Winchester
    • 1
  1. 1.Royal InfirmaryGlascowScotland

Personalised recommendations